Eckert & Ziegler stock retreats after recent TecDAX weakness

Published on 09/19/2026 at 19:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eckert & Ziegler stock closed at EUR 12.12 on Xetra on September 18, 2026, extending its one-year decline in the TecDAX. The shares remain under pressure after double-digit negative returns over three-, six- and twelve-month periods.

Photorealistischer Reinraum einer radiopharmazeutischen Produktionsanlage — Eckert & Ziegler DE0005659700 Medizintechnik: Forscher arbeiten in modernem Radiopharmazeutika-Reinraum mit Gloveboxen und Hot-Cells, Illustration mit AI erstellt.

Eckert & Ziegler stock (ISIN DE0005659700) closed at EUR 12.12 on Xetra on September 18, 2026, marking a modest daily decline and leaving the radiation technology specialist deep in negative territory over the past year.

Price weakness in TecDAX context

According to the TecDAX overview on September 16, 2026, Eckert & Ziegler shares traded at EUR 12.03 at 17:35:02 with a prior close of EUR 12.26, corresponding to an intraday loss of 1.88% on that day.finanzen.ch The TecDAX listing also shows that the stock fell 3.03% over the past three months, 2.45% over six months and 4.87% over one year, underperforming many peers in the technology-heavy index.finanzen.ch

The Xetra quote for Eckert & Ziegler on September 18, 2026, stood at EUR 12.12, down 0.11 EUR or 0.90% versus the previous close, with the market described as closed at 21:32 GMT+0.TradingView This price level is consistent with the TecDAX data and confirms that Eckert & Ziegler stock remains well below earlier highs from 2025.

Market capitalization and volatility

Per Xetra market data for Eckert & Ziegler SE as of September 18, 2026, the shares traded at EUR 12.12 with a market capitalization of about EUR 758.40 million, highlighting the mid-cap character of the company within the TecDAX.TradingView TradingView data also indicate that the stock has a beta of 1.22 and a volatility of 1.83%, suggesting that Eckert & Ziegler shares tend to move more than the broader market on active trading days.TradingView

Intraday data from a German real-time order book show that on September 19, 2026, Eckert & Ziegler was changing hands on Xetra at prices around EUR 12.37 with trades such as 114 shares at EUR 12.37 at 15:40:00 and 2 shares at EUR 12.44 at 15:22:46, underlining the relatively modest liquidity and narrow price band in the current environment.finanznachrichten.de For investors, the combination of mid-cap size, above-market beta and limited volume can mean more pronounced swings when sentiment around medical technology and nuclear medicine shifts.

Earnings calendar and investor perspective

The next reporting event is already visible in the market data: TradingView lists November 12, 2026, as the date for the next quarterly report, covering Q3 2026 for Eckert & Ziegler SE.TradingView Until then, the current pricing around EUR 12 and the one-year decline of 4.87% in the TecDAX overview give investors a reference point for how much improvement in revenue and earnings would be needed to change the narrative.finanzen.ch

In the absence of fresh half-year or quarterly figures within the last week in the available sources, the focus for many market participants is likely to remain on technical benchmarks and the upcoming Q3 date, particularly given the stock's clear underperformance over six and twelve months compared with the broader index.finanzen.ch For long-term shareholders, the current level below EUR 13 underscores how much value has been eroded since mid-2025, when the stock traded near EUR 18 according to historical data from a German stock portal.boerse.de

Stock price on Xetra

As of the most recent completed Xetra session on September 18, 2026, Eckert & Ziegler stock closed at EUR 12.12, down 0.90% from the prior close, on the Frankfurt-based electronic trading venue Xetra in Germany.TradingView This closing level and the associated market capitalization figures frame the current valuation for investors assessing the stock ahead of the Q3 2026 results.